Parallel Advisors’s Pelthos Therapeutics PTHS Stock Holding History

Parallel Advisors’s Portfolio PTHS Stock Details PTHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$105	Buy	+5	New	+$127	﹤0.01%	3978

Other funds holding PTHS

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Parallel Advisors's PTHS Position: Q3 2026 in Review

Parallel Advisors opened a new position in Pelthos Therapeutics (PTHS) in Q3 2026: 5 shares worth $105. The stake represents ﹤0.01% of the portfolio and ranks #3978 among its holdings.

4 funds tracked by Wall St. Rank hold PTHS as of Q3 2026.

Parallel Advisors held 5 shares of Pelthos Therapeutics worth $105 as of Q3 2026.
Pelthos Therapeutics was a new Parallel Advisors position in Q3 2026.
Pelthos Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3978 holding.
4 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.